Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5

Rhea-AI Summary

Cardinal Health (NYSE: CAH) will report second-quarter fiscal 2026 results on February 5, 2026, prior to the opening of trading on the New York Stock Exchange. The company will host a webcast discussion beginning at 8:30 a.m. Eastern.

Investors can access the live webcast and slide presentation through Cardinal Health's Investor Relations page with no access code required. Presentation slides and a replay will remain available on the Investor Relations page for 12 months.

Key Figures

Q1 FY2026 Revenue $64.0 billion Q1 FY2026 results

GAAP Operating Earnings $668 million Q1 FY2026, +18% year-over-year

GAAP Diluted EPS $1.88 Q1 FY2026, +11% year-over-year

Non-GAAP Operating Earnings $857 million Q1 FY2026, +37% year-over-year

Non-GAAP Diluted EPS $2.55 Q1 FY2026, +36% year-over-year

FY2026 EPS Guidance $9.65–$9.85 Raised non-GAAP EPS outlook, +17%–20%

Adj. Free Cash Flow $3.0–$3.5 billion Raised FY2026 guidance range

ASR Program Size $375 million Accelerated share repurchase initiated with Q1 FY2026 results

Market Reality Check

$208.48 Last Close

Volume Volume 2,509,667 is 1.35x the 20-day average, indicating elevated trading activity pre-announcement. normal

Technical Shares at $205.45 are trading above the 200-day MA of $163.09 and about 4.41% below the 52-week high of $214.93.

Peers on Argus

Key peers like COR, MCK, HSIC, ALC, and RMD show gains between 0.86% and 2.71%, while CAH was modestly lower by 0.13%, suggesting stock-specific positioning ahead of its earnings date rather than a uniform sector move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 04	Dividend declaration	Positive	+0.7%	Quarterly cash dividend of $0.5107 per share declared with set pay date.
Nov 03	M&A acquisition	Positive	-0.3%	Completion of Solaris Health acquisition expanding MSO provider footprint.
Oct 30	Earnings and guidance	Positive	+15.4%	Q1 FY2026 beat with raised non‑GAAP EPS and free cash flow guidance.
Sep 30	Network expansion	Positive	+1.6%	New Indianapolis distribution center to enhance pharma distribution network.
Sep 23	Earnings date set	Neutral	+4.8%	Scheduled Q1 FY2026 results release and webcast details.

Pattern Detected

Recent fundamental positives (earnings beat, outlook raise, network expansion) generally saw aligned positive price reactions, while the Solaris Health acquisition headline showed a mild negative divergence.

Recent Company History

Over the past several months, Cardinal Health reported strong Q1 FY2026 results with revenue of $64.0 billion, significant year‑over‑year growth in earnings, and raised FY2026 non‑GAAP EPS and free cash flow guidance, which aligned with a 15.43% price gain. The company also advanced its strategy via the Solaris Health acquisition and a new Indianapolis distribution facility. Dividend stability and prior earnings‑date scheduling both saw modest positive reactions, framing the newly announced Q2 FY2026 earnings date within a backdrop of constructive operational and capital‑return updates.

Regulatory & Risk Context

Active S-3 Shelf Registration 2025-08-12

An effective Form S-3ASR shelf filed on August 12, 2025 allows Cardinal Health to issue various securities over time, with 750 million common shares authorized and no preferred or Class B common shares outstanding as of June 30, 2025. Usage count is 0, indicating no takedowns from this shelf so far.

Market Pulse Summary

This announcement sets the timing for Cardinal Health’s Q2 FY2026 results on February 5, with a webcast at 8:30 a.m. Eastern. In context, the company recently delivered strong Q1 FY2026 growth, raised non‑GAAP EPS and free cash flow guidance, and initiated a $375 million accelerated share repurchase. Investors may watch for updates versus the $9.65–$9.85 EPS outlook, integration of Solaris Health, and any use of the effective S-3ASR shelf registration.

Jargon Translator

accelerated share repurchase

An accelerated share repurchase is a deal where a company hires a bank to buy back a large block of its own stock immediately on the open market, with the bank later settling the exact number of shares over time. For investors it matters because the immediate reduction in shares outstanding can raise per‑share earnings and often supports the stock price, but it also uses company cash or borrowing and can change liquidity and future growth funding.

form 4

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form S-3

Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.

restricted share units

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

shelf prospectus

A shelf prospectus is a regulatory filing that pre-approves a company’s plan to sell shares or bonds over time without needing a new registration each time. Think of it as a menu the company files with regulators that lets it quickly “take items off the shelf” and raise money when market conditions are favorable. Investors care because it signals the company can issue new securities on short notice, which can affect ownership dilution and share price.

AI-generated analysis. Not financial advice.

DUBLIN, Ohio, Jan. 6, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2026 on February 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.

To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; a provider of performance and data solutions; and a global manufacturer and distributor of medical and laboratory products. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.

Media:	Erich Timmerman
	(614) 757-8231
	Erich.Timmerman@cardinalhealth.com
Investors:	Matt Sims
	(614) 553-3661
	Matt.Sims@cardinalhealth.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-to-announce-second-quarter-results-for-fiscal-year-2026-on-february-5-302652902.html

SOURCE Cardinal Health, Inc.

FAQ

When will Cardinal Health (CAH) announce Q2 fiscal 2026 results?

Cardinal Health will release Q2 fiscal 2026 results on February 5, 2026, before the NYSE opens.

What time is the Cardinal Health (CAH) Q2 webcast on February 5, 2026?

The webcast discussion will begin at 8:30 a.m. Eastern on February 5, 2026.

How can I access the Cardinal Health (CAH) Q2 2026 webcast and slides?

Access the live webcast and slide presentation via Cardinal Health's Investor Relations page; no access code is required.

Will the Cardinal Health (CAH) presentation slides and replay be available after the webcast?

Yes. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.

Do I need to register to listen to Cardinal Health's (CAH) February 5, 2026 webcast?

No registration or access code is required; the webcast is available directly on the company's Investor Relations page.

Where should investors go to find Cardinal Health (CAH) Q2 fiscal 2026 materials after the event?

Investors should visit Cardinal Health's Investor Relations page to find the slides and replay for up to 12 months.